OpenURL Connection Search

Select item for more details and to access through your institution.

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
Published in:
2010
By:
- Lind JS;
- Meijerink MR;
- Dingemans AM;
- van Kuijk C;
- Ollers MC;
- de Ruysscher D;
- Postmus PE;
- Smit EF;
- Lind, Joline S W;
- Meijerink, Martijn R;
- Dingemans, Anne-Marie C;
- van Kuijk, Cornelis;
- Ollers, Michel C;
- de Ruysscher, Dirk;
- Postmus, Pieter E;
- Smit, Egbert F
Publication type:
journal article
Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial.
Published in:
2011
By:
- Gridelli C;
- Bennouna J;
- de Castro J;
- Dingemans AM;
- Griesinger F;
- Grossi F;
- Rossi A;
- Thatcher N;
- Wong EK;
- Langer C
Publication type:
Journal Article
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?
Published in:
2012
By:
- De Ruysscher D;
- Van Meerbeeck J;
- Vandecasteele K;
- Oberije C;
- Pijls M;
- Dingemans AM;
- Reymen B;
- van Baardwijk A;
- Wanders R;
- Lammering G;
- Lambin P;
- De Neve W;
- De Ruysscher, D;
- Van Meerbeeck, J;
- Vandecasteele, K;
- Oberije, C;
- Pijls, M;
- Dingemans, A M C;
- Reymen, B;
- van Baardwijk, A
Publication type:
journal article
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
Published in:
2012
By:
- Kuiper JL;
- Lind JS;
- Groen HJ;
- Roder J;
- Grigorieva J;
- Roder H;
- Dingemans AM;
- Smit EF;
- Kuiper, J L;
- Lind, J S W;
- Groen, H J M;
- Roder, J;
- Grigorieva, J;
- Roder, H;
- Dingemans, A M C;
- Smit, E F
Publication type:
journal article

Found: 4

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?

VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.